66316-1-Ig
antibody from Proteintech Group
Targeting: EPCAM
17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66316-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- EPCAM antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated EPCAM antibody (Cat. #66316-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IF, IHC, WB, ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2A2D5
- Vial size
- 20ul, 150ul
Submitted references Spherical nucleic acids-based cascade signal amplification for highly sensitive detection of exosomes.
Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis.
miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance.
Mutations in the coat complex II component SEC23B promote colorectal cancer metastasis.
Wang L, Deng Y, Wei J, Huang Y, Wang Z, Li G
Biosensors & bioelectronics 2021 Nov 1;191:113465
Biosensors & bioelectronics 2021 Nov 1;191:113465
Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis.
Meng X, Wang J, Zhou J, Tian Q, Qie B, Zhou G, Duan W, Zhu Y
Acta biomaterialia 2021 Jun;127:266-275
Acta biomaterialia 2021 Jun;127:266-275
miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance.
Han T, Zhang Y, Yang X, Han L, Li H, Chen T, Zheng Z
Molecular therapy. Nucleic acids 2020 Mar 6;19:1073-1085
Molecular therapy. Nucleic acids 2020 Mar 6;19:1073-1085
Mutations in the coat complex II component SEC23B promote colorectal cancer metastasis.
Yang C, Chen N, Li X, Lu D, Hou Z, Li Y, Jin Y, Gu J, Yin Y
Cell death & disease 2020 Mar 2;11(3):157
Cell death & disease 2020 Mar 2;11(3):157
No comments: Submit comment
No validations: Submit validation data